Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$16.93 - $26.82 $6,772 - $10,728
-400 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$21.86 - $34.77 $437 - $695
20 Added 5.26%
400 $10,000
Q2 2021

Aug 12, 2021

BUY
$29.55 - $39.15 $295 - $391
10 Added 2.7%
380 $12,000
Q1 2021

May 13, 2021

SELL
$31.52 - $39.28 $157 - $196
-5 Reduced 1.33%
370 $13,000
Q4 2020

Feb 12, 2021

BUY
$29.88 - $39.8 $11,205 - $14,924
375 New
375 $12,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.